Publicaciones en las que colabora con Eduardo Núñez (137)

2024

  1. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

    European Journal of Heart Failure, Vol. 26, Núm. 8, pp. 1687-1698

  2. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

  3. Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute Heart Failure

    JACC: Heart Failure, Vol. 12, Núm. 2, pp. 304-318

  4. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

  5. Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction

    Scandinavian Cardiovascular Journal, Vol. 58, Núm. 1

  6. β-Blocker Withdrawal and Functional Capacity Improvement in Patients with Heart Failure with Preserved Ejection Fraction

    JAMA Cardiology, Vol. 9, Núm. 4, pp. 392-396

2023

  1. Early glomerular filtration rate decline is associated with hemoglobin rise following dapagliflozin initiation in heart failure with reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 783-792

  2. Peritoneal and Urinary Sodium Removal in Refractory Congestive Heart Failure Patients Included in an Ambulatory Peritoneal Dialysis Program: Valuable for Monitoring the Course of the Disease

    CardioRenal Medicine, Vol. 13, Núm. 1, pp. 211-220

  3. Risk of death associated with incident heart failure in patients with known or suspected chronic coronary syndrome

    ESC Heart Failure, Vol. 10, Núm. 1, pp. 264-273

  4. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status

    JACC: Heart Failure, Vol. 11, Núm. 11, pp. 1611-1622

  5. Short-term Changes in Hemoglobin and Changes in Functional Status, Quality of Life and Natriuretic Peptides After Initiation of Dapagliflozin in Heart Failure With Reduced Ejection Fraction

    Journal of Cardiac Failure, Vol. 29, Núm. 5, pp. 849-854

2022

  1. Carbohydrate antigen 125 and risk of heart failure readmissions in patients with heart failure and preserved ejection fraction

    Scientific Reports, Vol. 12, Núm. 1

  2. Hospitalization following an emergency-department visit for worsening heart failure: The role of left ventricular ejection fraction

    Medicina Clinica, Vol. 159, Núm. 4, pp. 157-163

  3. Incidence, Treatment and Clinical Impact of Iron Deficiency in Chronic Heart Failure: A Longitudinal Analysis

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  4. Iron deficiency testing in acute heart failure. Much to do

    REC: CardioClinics, Vol. 57, Núm. 4, pp. 296-299

  5. Magnetic Resonance Assessment of Left Ventricular Ejection Fraction at Any Time Post-Infarction for Prediction of Subsequent Events in a Large Multicenter STEMI Registry

    Journal of Magnetic Resonance Imaging, Vol. 56, Núm. 2, pp. 476-487

  6. Optimal carbohydrate antigen 125 cutpoint for identifying low-risk patients after admission for acute heart failure

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 316-324

  7. Venous Leg Compression for Tissue Decongestion in Patients With Worsening Congestive Heart Failure

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review

    European Journal of Heart Failure, Vol. 23, Núm. 9, pp. 1445-1457

  2. CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 5, pp. 475-483